Oxidative stress is now believed to be an important factor in the development of hypertension in non-alcoholic fatty liver disease; increased blood pressure is found to be associated with NAFLD in patients with increased alanine transaminase concentrations (Lau et al., 2010[22]). Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.